Lithuania’s Biotech Momentum: Innovation, Scale-ups and Investment Opportunities

​Lithuania’s Biotech Momentum: Innovation, Scale-ups and Investment Opportunities

​Lithuania is emerging as one of Europe’s most dynamic biotechnology and life sciences hubs, with a rapidly growing ecosystem of start-ups, scale-ups, research talent and investment opportunities. This evening event will introduce the Lithuanian biotech and start-up ecosystem to the Berlin business, innovation and life sciences community.

​Hosted by Mr. Edvinas Grikšas, Minister of the Economy and Innovation of the Republic of Lithuania, the event will bring together Lithuanian biotech leaders, start-up founders and investors for a panel discussion on how Europe can safeguard and strengthen its biotechnology competitiveness in the long term.

​The discussion will highlight Lithuania’s fast-growing biotech sector, which has been expanding by around 25% annually, and explore why the country has become an attractive location for innovation-driven companies and investors. Many of today’s most promising Lithuanian biotech players started as research-driven start-ups and have since developed into internationally visible companies.

​Lithuania’s biotech ecosystem already includes strong examples across several high-value fields: Caszyme, working with CRISPR-Cas gene-editing technologies; Biomatter, developing AI-enabled tools for protein design and synthetic biology; Droplet Genomics, advancing microfluidics and high-throughput biological research tools; Atrandi Biosciences, developing next-generation single-cell analysis technologies; Genomika, working on DNA-based data storage; and Vugene, representing Lithuania’s new generation of biotech innovators. These companies demonstrate the breadth of Lithuania’s capabilities — from gene editing and protein engineering to single-cell technologies, diagnostics, synthetic biology and digital biotech.

​Agenda

​Keynote by Mr. Edvinas Grikšas
Minister of the Economy and Innovation of the Republic of Lithuania

​Panel moderated by Simona Šimulytė, Executive Director of LithuaniaBIO:

​Justinas Mačiulaitis
CEO, Kelifarma UAB

​Gražina Mykolaitytė-Nielsen
CEO, Vugene

​Gabrielė Poteliūnaitė
Principal, VC Balnord

​The event will offer insights into Lithuania’s biotech success story, the role of start-ups and scale-ups in building a competitive European life sciences sector, and the opportunities Lithuania presents for international cooperation, investment and strategic partnerships.